Sreyashi Basu

27PUBLICATIONS
225CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursInnate immunityGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (27)

|Oct 14, 2026
Immune biomarkers of response and resistance to ipilimumab and nivolumab in metastatic castration-resistant prostate cancer.

|May 07, 2026
Nivolumab plus ipilimumab for chemotherapy-refractory metastatic castration-resistant prostate cancer: results from the randomized portion of the phase 2 CheckMate 650 trial.

|Mar 10, 2026
Dual phagocytosis-checkpoint blockade revitalizes immune surveillance in mouse models of glioblastoma.

JongHoon Ha, Yifan Wang, Yifan Ma

|Jan 09, 2026
Macrophage-Dendritic Cell-T-Cell Tetrads Orchestrate Antitumor Immunity and Response to Checkpoint Blockade.

Mehdi Chaib, Muhammad Aminu, Shelley Herbrich

|Oct 08, 2025
Serial multiomics uncovers anti-glioblastoma responses not evident by routine clinical analyses.

Alexander L Ling, Jennifer Gantchev, Michael C Prabhu

|Sep 10, 2025
Loss of PTDSS1 in tumor cells improves immunogenicity and response to anti-PD-1 therapy.

Jielin Liu, Shelley Herbrich, Sreyashi Basu

Pageof 5

Frequent Collaborators

22 joint publications

Padmanee Sharma

13 joint publications

Sonali Jindal

9 joint publications

Sangeeta Goswami

7 joint publications

Rebecca Slack Tidwell